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ABSTRACT
Background The use of patient- facing health 
technologies to manage long- term conditions is 
increasing; however, children and young people may 
have particular concerns or needs before deciding to use 
different health technologies.
Aims To identify children and young people’s 
reported concerns or needs in relation to using health 
technologies to self- manage long- term conditions.
Methods A scoping review was conducted. We 
searched MEDLINE, PsycINFO and CINAHL in February 
2019. Searches were limited to papers published 
between January 2008 and February 2019. We included 
any health technology used to manage long- term 
conditions. A thematic synthesis of the data from 
the included studies was undertaken. We engaged 
children with long- term conditions (and parents) to 
support review design, interpretation of indings and 
development of recommendations.
Results Thirty- eight journal articles were included, 
describing concerns or needs expressed by n=970 
children and/or young people aged 5–18 years. Most 
included studies were undertaken in high- income 
countries with children aged 11 years and older. Studies 
examined concerns with mobile applications (n=14), 
internet (n=9), social media (n=3), interactive online 
treatment programmes (n=3), telehealth (n=1), devices 
(n=3) or a combination (n=5). Children and young 
people’s main concerns were labelling and identity; 
accessibility; privacy and reliability; and trustworthiness 
of information.
Discussion This review highlights important concerns 
that children and young people may have before using 
technology to self- manage their long- term condition. 
In future, research should involve children and young 
people throughout the development of technology, from 
identifying their unmet needs through to design and 
evaluation of interventions.
BACKGROUND
Patient- facing health technologies (eg, virtual reality, 
augmented reality, telehealth and medical devices) 
have the potential to address key healthcare chal-
lenges, and their use is rapidly expanding.1 Increas-
ingly, adults with long- term conditions (LTCs) 
self- manage their health,2 sometimes with remote 
clinical support and monitoring. This approach 
could reduce health system burden, while offering 
convenience for clinicianpatient engagement.3 
There is growing interest in the use of technologies 
to support children and young people (CYP) with 
LTCs.4
Involving CYP with LTCs in developing and 
using health technologies provides opportunities 
for enhancing their health and well- being.1 To 
date, there is limited research into the challenges 
of using technology and concerns felt by end- users, 
particularly CYP. Recent systematic reviews high-
light privacy and security issues associated with 
the use of mobile health applications (apps) for 
CYP46 and CYP wanting access to safe, moderated 
forums to communicate with peers.7 For example, 
the Brushing RemInder 4 Good Oral HealTh 
(BRIGHT) trial8 used a short messaging service to 
encourage CYP to brush their teeth. During the 
intervention development and trial design, CYP 
expressed concerns over who could access their 
What is already known on this topic?
 Ź The use of patient- facing technologies for 
children and young people (CYP) to self- 
manage long- term conditions (LTCs) is rapidly 
increasing.
 Ź There are many studies exploring the use or 
development of new health technology but few 
that explored CYP’s concerns about the use of 
this technology.
 Ź It is important to obtain stakeholders’ 
views (particularly CYP’s) about their use of 
technologies or treatments.
What this study adds?
 Ź We have identiied key concerns of CYP about 
their use of health technology to self- manage 
LTCs.
 Ź Concerns included labelling and identity; 
accessibility; privacy and reliability; and 
trustworthiness.
 Ź It is important to understand and address 
these concerns as they are potential barriers to 
engagement with health technologies
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Table 1 Eligibility criteria for studies within this review
Inclusion criteria Exclusion criteria
Population: CYP with physical and/or mental LTCs aged up to and including 18 years (no lower age limit). LTCs 
were deined as ‘those conditions for which there is currently no cure, and which are managed with drugs and 
other treatment’.78
Concept: concerns and needs of CYP in relation to health technology including privacy, stigma, security, views 
about barriers to how they use health technology and any information that CYP suggested they needed to know 
before using health technology.
Context: the focus was on health technologies that CYP engage or interact with to manage LTCs. Health 
technologies included: mobile apps; virtual and augmented reality; telehealth; digital health; digitised medical 
devices; gamiication/health gaming; receiving health information via SMS (digital health education messages); 
patient care/monitoring wearables; remote monitoring; consumer products (eg, Fitbit); and social media. All 
settings (eg, home, hospital and clinic) and countries were included. Studies examining hypothetical (prospective) 
use, (how CYP may use the technology and what their concerns may be) and those studying retrospectively (after 
CYP had used the technology, either in real life situation or in a user- testing scenario), were included.
Study design: qualitative, surveys/questionnaires, feasibility, acceptability, user- testing/usability and mixed 
methods (including any of these study designs undertaken within trials), where data from those <18 years or 
younger could be extracted.
Studies were excluded if they: (1) did not involve CYP 
with LTCs; (2) only explored parents’ or clinicians’ views, 
experiences, use or concerns about a health technology; 
(3) explored use of health technologies to manage acute 
conditions, diagnosis or for one- off measurements; (4) 
included technologies to enhance mobility, senses or provide 
medications (eg, hearing aids, mobility aids and prostheses); 
(5) exclusively included CYP aged over 18 years; (6) did not 
separate CYP’s and adults’ data within the study; and (7) 
were not published in English.
CYP, children and young people; LTCs, long- term conditions; SMS, short messaging service.
mobile phone numbers and how they could stop receiving text 
messages. Recent studies7 9 suggest that CYP may require specific 
information and guidance on privacy, security and data confi-
dentiality before participating in research involving healthcare 
technologies. This scoping review and associated stakeholder 
consultation aimed to identify empirical research reporting 
CYPs concerns and needs relating to the use of health technol-
ogies to self- manage LTCs and develop recommendations for 
technology developers and researchers.
METHODS
A scoping review10 was undertaken without quality assessments.11
Search strategy
Ovid MEDLINE, PsycINFO and CINAHL were searched in 
February 2019 using a strategy developed with an information 
specialist and modified for each database (see online supplemen-
tary appendix 1). The search was limited to papers published 
between January 2008 and February 2019 to ensure relevance to 
current health technologies.
Eligibility
table 1 outlines the review inclusion and exclusion criteria.
Study selection
Records were deduplicated in Endnote and managed using Covi-
dence. JM- K screened title and abstracts, with 20% of records 
double- screened (SB and VS). Agreement rate and Cohen kappa 
coefficients were calculated to measure inter- rater reliability. 
Three reviewers (JM- K, SB and CM) undertook screening of 
full- text records independently. When uncertainty about inclu-
sion arose, articles were discussed (JM- K, CM, SB and AD) until 
a consensus was reached.
Data extraction
Data were extracted by JM- K (with AD and CM each inde-
pendently replicating extraction of 50% of the studies) using a 
prepiloted template. Data extracted included: lead author; year 
of publication; country; study participant details (age, number, 
sex and LTC); study design; setting where technology was 
used; retrospective or prospective use; concerns or information 
needed before using the technology; whether CYP were involved 
in the scoping or design of the technology; and any quotations to 
support the concerns extracted.
Data synthesis
Bubble plots highlight patterns and gaps in data and identify 
the number of included studies by country and publication year. 
Thematic analysis of the findings of each study was undertaken. 
JM- K and SB read through extracted qualitative (quotations and 
interpretation from the primary study authors) and quantitative 
data to identify concerns and needs and assign themes.12
Stakeholder consultation
Throughout the project, we engaged with CYP and parent stake-
holders who had used health technologies to manage LTCs. To 
explore the context for this review from the perspective of CYP 
(April 2019), JM- K and SS facilitated a discussion with (n=4) 
stakeholders, two CYP aged 13 and 15 years and their mothers, 
to determine their views on concerns and informational needs.
Following the review (October 2019), we shared the find-
ings with CYP and parents from the NIHR Generation R Young 
Persons Advisory Group (YPAG). The consultation was a face- 
to- face meeting with 15 CYP (age 918 years) and 4 parents 
(who have children with LTC). Participants noted and discussed 
findings that interested or surprised them. Participants were 
invited to make recommendations for health professionals devel-
oping self- management support health technologies (based on 
the review findings) on Post- it notes and discuss these within the 
group. The outcomes of this discussion supplemented the review 
findings and informed the recommendations.
RESULTS
Study selection
A total of 18 365 unique records were identified through the 
electronic searches. There was a 95% agreement rate in the 
3673 double- screened abstracts(moderate kappa agreements). 
No potentially eligible studies were missed. Single screening was 
undertaken for the remaining 14 692 records. Many excluded 
papers did not include CYPs concerns or perspectives (eg, only 
proxy views from parents or clinicians), or reported the tech-
nology use outside the scope of this review. Thirty- eight studies 
were included (see figure 1).
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Figure 1 PRISMA low chart. CYP, children and young people; 
PRISMA, Preferred Reporting Items for Systematic Reviews and Meta- 
Analyses.
Characteristics of included studies
All studies (table 2) were published between 2009 and 2019 
and undertaken in Australia1315 (n=3), Canada1622 (n=7), 
England2331 (n=9), Italy32 (n=1), the Netherlands33 (n=1), New 
Zealand34 (n=1), Nigeria35 (n=1), Spain36 (n=1), Sweden37 38 
(n=2), USA3949 (n=11) and Wales50 (n=1). Studies included 
CYP with the following LTCs: asthma (n=7), type 1 diabetes 
(n=5), chronic kidney disease (n=3), cancer (n=3), obesity 
(n=3), cerebral palsy/spina bifida (n=2), attention deficit hyper-
activity disorder (ADHD) (n=2) and HIV, idiopathic scoliosis, 
colorectal conditions, chronic fatigue syndrome/myalgic enceph-
alitis with n=1 study each. Figure 2 shows the distribution of 
studies by country and publication date.
Most studies were exclusively qualitative (n=26, 
68%),13 14 16 17 2024 26 27 2931 34 3638 40 4244 4750 while other study 
designs such as user testing, pilot or feasibility studies and one 
randomised controlled trial each included some qualitative data 
(n=12, 32%).15 18 19 25 32 33 35 39 41 45 46 Only seven studies included 
participants under 11 years.17 24 2628 31 34 The age range of CYP 
represented was 518 years.
Technologies were categorised using a previously reported 
typology51: internet (eg, websites, forums, chat rooms and 
e- tools) (n=9)13 16 23 26 3335 37 46; social media (dedicated 
platforms, eg, YouTube, Twitter, Facebook and Instagram) 
(n=3)4749; mHealth (eg, mobile phone apps and text messaging) 
(n=14)18 19 22 24 28 29 31 3945; telehealth (eg, video conferencing 
and telephone consultations) (n=1)17; interactive online treat-
ment programmes (n=3)14 15 50; and devices (eg, wearables and 
other devices/hardware)25 30 32 (n=3). Five studies involved 
combinations of technologies.20 21 27 36 38
Concerns and needs expressed by CYP
Regardless of technology type, many concerns reported by CYP 
were similar across studies (see table 3). There were four over-
arching themes, summarised below, with quotations illustrating 
key concerns in the words of CYP themselves (table 4). Full list 
of quotations per study is provided in online supplementary 
appendix 2.
Labelling and identity
CYP were concerned that stigma could arise from technology 
visibility, for example, the potential for social embarrassment 
prevented them from using devices in public.14 Many technol-
ogies were designed to enable CYP to engage with an online 
community of users, which in some cases included other CYP 
from the healthy population, which led to CYPs concerns about 
cyberbullying.14 50 Some CYP felt that technologies involving 
online communities should have separate condition- specific 
spaces to reduce the risk of discrimination and support inclu-
sivity.20 44 48 Suggestions included private messaging or chat 
options.20 Conversely, some CYP expressed concerns about tech-
nologies that exclusively brought together CYP with the same 
condition in forums or chatrooms.16
Overall, there was a tension between the need for normalisa-
tion and the risk of discrimination. For some CYP, being normal 
meant feeling part of a community of other CYP who shared 
their condition/s and experience/s; while for others, it was also 
about feeling included in a community of healthy peers.
Accessibility
This included usability concerns regarding the age and develop-
mental appropriateness of content26 31 34 38 and risks associated 
with bringing CYP from a broad age range together in forums or 
chat rooms,28 such as an increase in perceived noise that might 
prevent individual voices being heard and understood.16 CYP 
also expressed preferences for plain language and the absence of 
jargon or medical terminology that they would find difficult to 
understand.23 27 36
CYP identified limited access to Wi- Fi in hospitals, at home 
and in the community as possible barriers to some technolo-
gies.26 29 Rules imposed in schools regarding mobile phone use 
were also highlighted.41 45
CYP highlighted financial costs28 31 associated with using 
mobile data45 to access apps as well as the impact on device 
storage capacity43 and challenged the assumption that all CYP 
used social media or had access to smartphones.49
Privacy
Some privacy concerns were linked to technology visibility that 
may draw attention to an undisclosed condition.18 25 CYP high-
lighted the potential for unwanted attention35 44 and questioning 
that may arise from using a device.25 Concerns surrounding 
data sharing and confidentiality of personal information were 
also evident.14 22 33 39 48 CYP had preferences about whom they 
would share data with and were concerned about the perceived 
dangers and negative implications of sharing data widely.25 31 40 
For example, the risks of being hacked13 26 and the importance 
of privacy settings24 in various social media platforms and apps; 
privacy related to content that CYP created50 and fears of being 
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Table 2 Summary of included studies (n=38)
Lead author 
and year study 
published Study design Country of study
Mean age 
(years)
Study 
participants 
within age range 
(total sample 
size)
Study participants' 
female (%) Study participants: LTC
CYP involved in 
the design of the 
technology?
Barnfather
(2011)
Qualitative (individual interviews) Canada 14.6 22* (27) 12 (44.4)* Cerebral palsy and spina biida. Yes
Bevan Jones
(2018)
Qualitative (interviews and focus 
groups)
Wales 15.85† 11 (33) 7 (64) Depression. Yes
Boydell
(2010)
Qualitative (individual interviews) Canada NR 30 (30) 13 (43.3) Variety of mental health conditions 
and neurodevelopmental disorders.
No
Bradford
(2015)
Qualitative (focus group 
discussions)
Australia NR 17 (129) 9 (53) Mental health. No
Brigden
(2018)
Qualitative (individual interviews) England 14.89 9 6 (66.6) Chronic fatigue syndrome and 
myalgic encephalomyelitis.
Yes
Britto
(2012)
Pilot or feasibility study 
(questionnaires)
USA 15.2 12‡ (19) 10 (52.6) Asthma. No
Cafazzo
(2012)
Codesign plus clinical pilot of 
intervention (interviews and 
questionnaires)
Canada 14.9 6 involved in 
design (26 in total 
within full study)
NR Type 1 diabetes. Yes
Cai
(2017)
Qualitative (interviews and focus 
groups)
England NR 29 19 (65.5) Juvenile idiopathic arthritis. Yes
Carpenter
(2016)
Qualitative (individual interviews) USA 14.7 20 9 (45) Asthma. No
Clark
(2018)
Qualitative (interviews) Australia 15.2 8 (29) 0 (0) Anxiety (with or without 
depression).
No
Dominguez
(2017)
Qualitative (interviews) plus 
questionnaire
Spain 18.7 9
(20)
8 (88.9) Cancer. No
Donzelli
(2017)
Survey/questionnaire Italy 14.65 336 (364) 301 (82.7)§ Idiopathic scoliosis. Yes
Dulli
(2018)
Pilot or feasibility study 
(qualitative and questionnaire)
Nigeria NR 41 22 (53) – total HIV. No
Holmberg
(2018)
Qualitative (individual interviews) Sweden NR 20 11 (55) Obesity. No
Howard
(2017)
Usability/user testing
(questionnaires and interviews)
England 13.4 7 2 (28.6) Asthma. Yes
Huby
(2017)
Qualitative (individual interviews) England NR 26 12 (46.2) Chronic kidney disease. Yes
Jibb
(2018)
Pilot study (including interviews 
and questionnaires)
Canada NR 20 in qual
(40 in larger study)
9 (45) Cancer. Yes
Knibbe
(2018)
Qualitative (focus group 
discussions)
Canada 14.4† 8 5 (62.5) Cerebral palsy. No
Maurice- Stam
(2014)
Pilot study (including 
questionnaires)
The Netherlands NR 12 (12) NR Cancer. No
Mulvaney
(2013)
Survey/questionnaire USA 15.2 53 31 (58) Asthma. No
Nicholas
(2009)
Qualitative (individual interviews) Canada 15 10 (24) NR Chronic kidney disease. Yes
Nightingale
(2017)
Qualitative (individual and joint 
interviews)
England NR 17 8 (47.1) Chronic kidney disease. Yes
Nordfeldt
(2013)
Qualitative (focus group 
discussions)
Sweden NR 24 (24) 11 (45.8) Type 1 diabetes. No
Powell
(2017)
  Qualitative (interviews) England 9.6† 5 (5) 2 (40) ADHD. No
Ramsey
(2018)
Qualitative (individual interviews) USA 15.4 20 10 (50) Asthma. No
Raval
(2017)
Qualitative (joint interviews) USA NR 2 (6) NR Colorectal diseases. No
Rivera
(2018)
Qualitative (focus groups) plus 
questionnaires
Canada 14.7 19 13 (68) Obesity. Yes
Roberts
(2016)
Qualitative (individual and joint 
interviews) plus questionnaire
USA 14.7 20 9 (45) Asthma. No
Schneider
(2019)
Usability/user testing (including 
qualitative)
USA 14.4 20 (20) 11 (55) Asthma. Yes
Simons
(2016)
Qualitative (focus group 
discussions) plus questionnaires
England NR 8 (8) 1 (12.5) ADHD. Yes
Stewart
(2018)
Qualitative (individual interviews) England 12.86 8 5 (62.5) Asthma. No
Continued
 on June 3, 2020 at B
V
A
. P
rotected by copyright.
http://adc.bm
j.com
/
A
rch D
is C
hild: first published as 10.1136/archdischild-2020-319103 on 22 M
ay 2020. D
ow
nloaded from
 
5Blower S, et al. Arch Dis Child 2020;0:1–12. doi:10.1136/archdischild-2020-319103
Original research
Lead author 
and year study 
published Study design Country of study
Mean age 
(years)
Study 
participants 
within age range 
(total sample 
size)
Study participants' 
female (%) Study participants: LTC
CYP involved in 
the design of the 
technology?
Thabrew
(2016)
Qualitative (focus group 
discussions)
New Zealand 12.55† 22 10¶ (45.5) Variety of long- term physical 
conditions.
No
Vaala
(2018)
Survey/questionnaire USA NR 134 75 (56) Type 1 diabetes. No
Van Rensburg
(2016)
Qualitative (individual interviews) USA 16.1† 20 (20) 15 (75) Variety of mental health conditions 
and neurodevelopmental disorders.
No
Waite- Jones
(2018)
Qualitative (interviews and focus 
groups)
England 13.6† 9 9 (81.8) Juvenile arthritis. Yes
Woolford
(2013)
Qualitative (interviews and focus 
groups)
USA 16 11 8 (73)** Obesity. No
Wuthrich
(2012)
RCT (including questionnaire) Australia 14.6 24 (43) 16 (66.7) Anxiety. Yes
Yi- Frazier
(2015)
Qualitative (interviews and focus 
groups)
USA 16.4 20 (20)†† 13 (65) Type 1 diabetes. No
*27 in total signed up and 22 participated in the qualitative research; subsequent percentages are % of total enrolled.
†Mean age not reported in the original study but calculated from raw data.
‡Only intervention participants (these are the only participants who provided concerns).
§These igures relate to the 364 approached not the 336 who participated in the study.
¶Estimate calculated from proportions provided in the study.
**Percentages reported in the study appear incorrect so have been adjusted in this table.
††20 CYP were enrolled but only 10 had individual interviews and 5 attended a focus group.
ADHD, attention deicit hyperactivity disorder; CYP, children and young people; LTC, long- term condition; RCT, randomised controlled trial.
Table 2 Continued
Figure 2 Included studies by publication date and country.
monitored or watched by parents and/or clinicians17 24 30 47 ; and 
the permanence of data on websites and apps.13
Ultimately, CYP desired control over their data and privacy; 
they sought a balance between safety, confidentiality, anonymity 
and the option to foster connection with others by putting a 
face to the name21 and sharing personal information if they so 
choose.
Trustworthiness and reliability
CYP were generally wary of online information (through 
websites or apps)27 37 unless it was perceived to be from a trusted 
official source, for example, from recognisable organisations or 
endorsed by clinicians with expertise in their condition.23 26 29 36 38 
They also raised concerns about images or content that could 
be perceived as overly negative or alarmist about their condi-
tion,36 48 although some CYP were concerned about images that 
they perceived to be unrealistic or idealised (particularly in rela-
tion to body image).37
Some CYP expressed discomfort or unease with the introduc-
tion of technologies that reduce face- to- face contact with their 
clinician. CYP were particularly concerned about the potential 
for lack of clinician responsiveness19 47 and the impact on their 
ability to form an open, honest and therapeutic relationship17 
as well as the risk of clinicians missing important non- verbal 
cues.13 30
Linked to this, a general fear of misinterpretation was also 
identified.47 CYP expressed concerns that information recorded 
on devices (rather than in conversation) could land them in 
trouble with limited opportunity to explain their side of the 
story30
Stakeholder consultation
When discussing the findings with CYP and parents, they 
expressed surprise at the level of concern for cyberbullying 
in relation to using health technologies to manage an LTC. 
However, they concurred with concerns identified in the review 
relating to security of data and information. They were surprised 
by studies reporting that language was not age appropriate, 
as they presumed that mobile apps would at least be word- 
friendly for children if that was the target end user. The group 
noted that CYP will have different reasons and motivations 
for using technology and felt it was important to ensure that 
CYP were involved early in technology development and to not 
underestimate the input and impact that CYP can have. They 
also suggested gamification to help young children with tech-
nology. The group felt incorporating passcodes, or other forms 
of security, was important to ensure data security and access.
DISCUSSION
Main findings
This review has highlighted CYPs specific concerns about the 
use of technology to self- manage LTCs including labelling and 
identity; accessibility; privacy; and trustworthiness of informa-
tion. Most studies were undertaken in high- income countries 
and mainly sought the views of CYP aged 11 years and older 
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Table 3 Summary of technologies and related concerns raised by CYP
Lead author and 
date
Age range 
(years)
Study participants: long- 
term health condition
Type of technology and 
brief description
Setting (where 
technology was 
studied) Use of technology Concerns
Barnfather (2011) 12–18 Cerebral palsy and spina 
biida.
Internet
(online support).
Home for 25 sessions. Retrospective.  Ź Stigma/grouping by 
condition.
 Ź Noise within chat room.
 Ź Usability (age 
appropriateness – too broad 
an age range).
Bevan- Jones
(2018)
13–18 Depression. Interactive online treatment 
programme
(psychoeducation 
multimedia programme: 
MoodHwb).
Discussed during 
interviews and focus 
groups.
Prospective.  Ź Security.
 Ź Conidentiality.
 Ź Discomfort/unease with 
technology.
Boydell (2010) 7–18 Variety of mental 
health conditions and 
neurodevelopmental 
disorders.
Telehealth
(telepsychiatry).
Clinic (interviewed after 
teleconsultation).
Retrospective.  Ź Discomfort/unease with 
technology.
 Ź Privacy – not wanting others 
to see or know.
 Ź Dificulty forming 
therapeutic relationship 
due to format (time, not 
knowing the person).
Bradford
(2015)
12–18* Mental health. Internet
(electronic mental health 
assessment).
Hypothetical (e- tool 
described in interviews).
Prospective.  Ź Privacy – not wanting others 
to see or know.
 Ź Data security.
 Ź Fear of misinterpretation.
 Ź Permanence of written 
information.
 Ź Discomfort/unease with 
technology.
Brigden (2018) 12–17 Chronic fatigue syndrome and 
myalgic encephalomyelitis.
Internet
(online resources).
Discussion of past use of 
online resources during 
interviews.
Retrospective.  Ź Trustworthiness of 
information – needs to be 
‘oficial’ or ‘reliable’.
 Ź Usability of technology (age 
appropriate; no jargon).
Britto (2012) 13–18 Asthma. mHealth
(text messaging on mobile 
phone).
Daily life (home, school 
and so on) for 3 months.
Retrospective.  Ź Privacy – not wanting others 
to see or know.
 Ź Data security.
 Ź Information being 
misinterpreted.
 Ź Permanence of written 
information.
 Ź Discomfort/unease with 
technology.
Cafazzo (2012) 12–16 Type 1 diabetes. mHealth
(smartphone app).
Daily life (home, school 
and so on).
Retrospective.  Ź Stigma.
 Ź Privacy – not wanting others 
to see or know.
 Ź Functionality of technology.
Cai (2017) 10–18* Juvenile idiopathic arthritis. mHealth
(smartphone app).
Clinic. Retrospective.  Ź Privacy – not wanting others 
to see or know.
 Ź Data security.
 Ź Control over how their data 
are shared.
Carpenter (2016) 12–16 Asthma. mHealth
(smartphone apps).
  Retrospective.  Ź Privacy (not wanting others 
to see or know).
Clark (2018) 12–18 Anxiety (with or without 
depression).
Interactive online treatment 
programme
(online anxiety disorder 
treatment programme).
Psychology clinics, school 
or participant’s house.
Prospective.  Ź Stigma of condition and 
identiication through 
technology use.
 Ź Conidentiality.
 Ź Control over decisions made.
Dominguez (2017) 14–18* Cancer. Internet and social media
(internet searches about 
LTC; Facebook, Twitter and 
Instagram; also blogs).
Interviews – discussion 
about technology.
Prospective.  Ź Information being negative 
or unreliable.
 Ź Usability of technology 
(age- appropriate language; 
no jargon).
 Ź Discomfort/unease with 
technology.
Donzelli (2017) NR Idiopathic scoliosis. Device
(thermobrace plus sensor 
with reading software).
Daily life (survey in 
waiting room).
Retrospective.  Ź Control over how their data 
are shared.
Dulli (2018) 15–18* HIV. Internet
(online support group).
Daily life (home, school 
and so on).
Retrospective.  Ź Stigma.
 Ź Privacy – not wanting others 
to see or know.
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Lead author and 
date
Age range 
(years)
Study participants: long- 
term health condition
Type of technology and 
brief description
Setting (where 
technology was 
studied) Use of technology Concerns
Holmberg (2018) 13–16 Obesity. Internet
(online weight, food and 
health information).
Discussion about past use 
in interviews.
Retrospective.  Ź Trustworthiness of 
information.
 Ź Realistic information and 
images need to be used.
Howard (2017) 11–16 Asthma. Device
(electronic monitoring 
device).
Home. Retrospective.  Ź Control over how their data 
are shared.
 Ź Stigma.
 Ź Privacy – not wanting others 
to see or know.
Huby (2017) 5–17 Chronic kidney disease (CKD). Internet
(web- based support for 
CKD).
Interviews conducted in 
hospital.
Prospective.  Ź Access to technology (Wi- Fi).
 Ź Age- appropriateness needed 
for technology.
 Ź Trustworthiness of 
information.
 Ź Privacy – not wanting others 
to see or know.
 Ź Data security.
Jibb (2018) 12–17 Cancer. mHealth
(smartphone app).
Home use for 28 days. Retrospective.  Ź Responsiveness of 
healthcare professionals.
Knibbe (2018) 12–18 Cerebral palsy. Internet, social media, 
mHealth (Facebook,Youtube, 
pedometer, itness app and 
active video games).
Hospital. Prospective.  Ź Inclusivity of people with 
conditions.
 Ź Stigma (cyberbullying).
 Ź Privacy – not wanting others 
to see or know.
Maurice- Stam (2014) 11–17 Cancer. Internet
(website with secure chat 
room).
Not speciied but outside 
of clinic.
Retrospective.  Ź Privacy – not wanting others 
to see or know.
Mulvaney (2013) 12–18 Asthma. mHealth
(using phone to monitor 
asthma).
Daily life (home, school 
and so on).
Retrospective.  Ź Access to technology (within 
school).
Nicholas (2009) NR Chronic kidney disease. Internet
(email and online social 
support network).
Daily life (home, school 
and so on).
Retrospective.  Ź Privacy – not wanting others 
to see or know.
 Ź Control over how their data 
is shared.
 Ź Unease/discomfort with 
technology.
Nightingale (2017) 5–18 Chronic kidney disease. Internet and mHealth
(apps and websites).
During interviews. Prospective.  Ź Trustworthiness of 
information/technology.
 Ź Access to technology 
(inding information).
 Ź Functionality of technology 
– data on phone.
 Ź Age appropriateness 
(gamiication).
 Ź Unease/discomfort with 
technology.
Nordfeldt (2013) 10–17 Type 1 diabetes. Internet and social media
(broad deinition).
Clinic (focus groups). Prospective.  Ź Trustworthiness of 
information/technology.
 Ź Control over who they share 
their data with.
 Ź Usability of technology (age- 
appropriate language).
 Ź Privacy – others seeing or 
knowing.
 Ź Discomfort/unease with 
technology.
Powell (2017) 8–13 ADHD. mHealth
(smartphone apps).
Interview location 
(participant's home).
Retrospective.  Ź Functionality of technology.
 Ź Usability of technology (age 
appropriate).
 Ź Access to technology (cost).
Ramsey (2018) 13–18 Asthma. mHealth
(smartphone apps).
Some use in real life; 
some hypothetical use in 
interviews.
Prospective.  Ź Control over how their data 
is shared.
Raval (2017) ? NR
(3-16)
Colorectal diseases. mHealth
(smartphone apps).
During interviews 
(discussion about apps).
Prospective.  Ź Stigma.
 Ź Privacy – not wanting others 
to see or know.
 Ź Usability of technology.
 Ź Condition- speciic 
technology.
 Ź Functionality of technology 
(data on phone).
Table 3 Continued
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Lead author and 
date
Age range 
(years)
Study participants: long- 
term health condition
Type of technology and 
brief description
Setting (where 
technology was 
studied) Use of technology Concerns
Rivera (2018) 12–18 Obesity. mHealth
(smartphone apps).
Discussion about apps in 
focus groups.
Prospective.  Ź Burden of tracking details.
 Ź Privacy – not wanting others 
to see or know.
Roberts (2016) 12–16 Asthma. mHealth
(smartphone apps).
Daily life (home, school 
and so on).
Retrospective.  Ź Privacy – not wanting others 
to see or know.
 Ź Stigma/grouping by 
condition.
Schneider (2019) 12–17 Asthma. mHealth
(smartphone apps).
Daily life (home, school 
and so on).
Retrospective.  Ź Functionality of technology.
 Ź Access to technology (school 
and data).
Simons (2016) 12–13 ADHD. mHealth
(text message and app for 
remote monitoring).
During focus groups 
- discussion about 
technology.
Prospective.  Ź Access to technology (school 
and WiFi).
 Ź Trustworthiness of 
information/technology.
Stewart (2018) 11–15 Asthma. Device
(electronic monitoring 
devices).
Daily life (home, school 
and so on).
Retrospective.  Ź Privacy – not wanting others 
to see or know.
 Ź Being monitored or 
watched.
 Ź Fear of misinterpretation.
Thabrew (2016) 8–17 Variety of physical conditions. Internet and interactive 
online treatment 
programmes
(online support and e- 
therapy).
Discussed in focus groups 
(hospital).
Prospective.  Ź Usability of technology 
(age- appropriateness).
Vaala (2018) 13–17 Type 1 diabetes. Internet
(online questionnaire to 
sharing personal data with 
peers).
Clinic. Prospective.  Ź Control over how their data 
is shared.
van Rensburg (2016) 14–18 Variety of mental 
health conditions and 
neurodevelopmental 
disorders.
Social media
(broad but did speciically 
include facebook).
n/a Prospective.  Ź Responsiveness of 
healthcare professionals.
 Ź Fear of misinterpretation.
 Ź Being monitored or 
watched.
Waite- Jones (2018) 10–18 Juvenile arthritis. mHealth
(smartphone apps).
Discussion in focus 
groups in clinic.
Prospective.  Ź Security.
 Ź Control over who how their 
data is shared.
 Ź Access to technology (cost).
 Ź Usability 
(age- appropriateness).
Woolford (2013) 13–18 Obesity. Social media (Facebook). Discussion in focus 
groups.
Prospective.  Ź Privacy – not wanting others 
to see or know.
 Ź Negative content.
 Ź Stigma.
Wuthrich (2012) 14–17 Anxiety. Interactive online treatment 
programme
(Cool Teens cCBT).
Daily life (home, school 
and so on).
Retrospective.  Ź Privacy – sharing personal 
data.
Yi- Frazier (2015) 14–18 Type 1 diabetes. Social media
(Instagram).
Daily life (home, school 
and so on).
Retrospective and
prospective.
 Ź Privacy – not wanting others 
to see or know.
 Ź Access to technology 
(smartphone).
*Age range of total sample exceeded 18 years, but reviewers were able to isolate data pertaining only to CYP whose age range met our inclusion criteria.
CYP, children and young people.
Table 3 Continued
in relation to a wide range of health technologies. The focus on 
older CYP possibly reflects difficulties that researchers expect to 
encounter when undertaking research with children52 and indi-
cates a gap in knowledge about the concerns of CYP under 11 
years. The most common LTCs studied included type 1 diabetes, 
asthma and mental health conditions. Included studies generally 
had small samples. Many studies were excluded because they 
focused on the views and concerns of parents and/or clinicians 
only.
Our findings in relation to the literature
The use of health technologies by CYP to manage LTCs is increasing 
with many studies describing their development, acceptability and 
use by CYP45 5361; effectiveness53 6264; and compliance by CYP.41 57 
However, there is limited literature on the concerns that CYP may 
have when (or before) using a health technology for self- managing 
their LTC, and no review has specifically explored these concerns.
Our results indicate that the views of CYP with LTC are 
under- represented in the literature. Many potentially eligible 
studies reported solely on clinicians or parents views or failed 
to separate out concerns expressed by CYP and adults. As previ-
ously reported, primary studies exploring CYPs concerns tend 
to involve healthy populations63 65 66 (eg, schoolchildren) rather 
than CYP with LTCs, even when evaluating the use of technolo-
gies that are designed for use by CYP with LTCs. Authentic user 
involvement in technology design and research is important and 
increasingly required by funders; CYP with LTCs are uniquely 
placed to explain their concerns about new technologies.
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Table 4 Quotations to illustrate identiied themes
Themes and example concerns Illustrative quotes*
Labelling and dentity
Stigma ‘In assembly at school when there’s lots of people there. I’m taking it out, and most people have normal inhalers, and I’m pulling this massive thing 
out. Even the teachers would be looking at me like “what’s that?” There’d be a lot of questions especially the teachers, because they would want to 
know what it is and everything’. (Adolescent, exact age unknown)25
Cyberbullying ‘The problem with an online chatroom is you’re going to get people who don’t actually need help and they don’t need to be on the website at all. 
They’re like ”Hey guys, you know what would be funny, making fun of these depressed kids”’. (14 years)14
Inclusivity ‘With some of the apps or even like a blog and stuff, you could have a speciic, um, part or like theme for disabled so that people who are like…you'd 
be talking to people who understand what you're going through in a way’. (12 years)20
‘I personally don’t like being grouped in speciically with people with disabilities, because it makes me think I’m not normal if I’m being stuck with 
other people who have disabilities too. It makes me focus on the fact that I’m different, and I don’t really like that’. (Adolescent, age not stated)16
Accessibility
Usability ‘I’ve had a look on the NHS site… it’s quite wordy and that sort of thing I wouldn’t necessarily understand… it’s sort of doctorised… it’s not 
necessarily aimed at young people’. (Adolescent, exact age unknown)23
Financial cost ‘… [Y]ou have to like buy them but that’s annoying cos they should be free…I haven’t even got a credit card’. (Adolescent, exact age unknown)28
Access to WiFi ‘Sometimes, when I don’t have WiFi it is hard for me’. (Exact age unknown)45
School rules ‘Having it [the app] in class would be helpful, cause they say you’re not allowed to have a phone in class. I can’t have it out in any of my classes … in 
the middle of the day, if you have trouble breathing you might want to record it so you can tell your pulmonologist’. (Age unknown)45
Privacy
Data sharing and conidentiality ‘I don’t really like the idea of it being on Facebook… I mean people can hack into you to see what you’ve been writing and people can, without 
hacking into you; see what you’ve written…’ (Age unknown)26
Being monitored or watched ‘Hmm err it was a little bit spyee … because they are checking up to see if I’m taking my inhaler by watching me instead of asking me’. (Adolescent, 
exact age unknown)30
Control ‘I want to be very certain of exactly what they can see’. (Age not stated)42
Trustworthiness and reliability Most of the sites regarding stuff like diet are like forums, so anyone can post, so there’s not really that much reliability…t he Kidney Foundation or 
something, that’s pretty reliable obviously ’cause it’s a government website, so I use that mostly’. (17 years)27
Discomfort or unease ‘I might not get the same level of attention and you know, kind of therapeutic qualities that I would if I was in a room with a therapist, and it’s not 
like personal, you know, you know what I mean, because you’re not right there with them, talking about it, you’re on a keyboard talking about it’. 
(Adolescent, exact age unknown)47
Responsiveness
Fear of misinterpretation ‘Yeah, I mean, there’s inside jokes between me and my friends, and if he or she didn’t know about it, she [provider] might take that the wrong way… 
I don’t know how they [providers] would put it – as unsafe, or between me and my friends as a joke. And I wouldn’t know how they would take it’. 
(Age 14–17 years)47
*Age and terminology (eg, adolescent and child) as reported by primary study.
We did not find any studies examining CYP concerns 
regarding the use of virtual or augmented reality technologies to 
self- manage LTCs. This may reflect wider- reaching tendencies by 
researchers to only seek proxy views about how CYP use tech-
nology to manage an LTC.
Our findings are consistent with a previous review on the use 
of digital clinical communication (eg, telehealth) for CYP with 
long- term mental health conditions reporting that most studies 
focused only on satisfaction, acceptance or feasibility of the tech-
nology.67 While these issues are important, a broader focus on 
general concerns contributes to our understanding of potential 
barriers to technology use.
We identified a range of concerns, several clustered around a 
theme of labelling and identity and highlighting that CYP with 
LTCs are a diverse group, and those with the same condition 
may have differing concerns about the use of interactive technol-
ogies. CYP varied in whether they wanted their condition to be 
known, to interact with others with the same condition, or with 
healthy CYP. These concerns are supported by previous litera-
ture that highlights variations in how CYP wish to use online 
forums.68 69 The potential risk of cyberbullying identified in 
some studies is supported by a recent review about risks asso-
ciated with the use of social media by CYP.70 In addition, CYP 
were particularly cautious about stigma arising from the use of 
technologies to manage mental health conditions and sexually 
transmitted infections.71
Accessibility of the technology, through age- appropriate 
language, style and physical access, was important. This concern 
is supported by other literature involving CYP without LTCs, 
for instance the ability of school- aged CYP to identify and access 
information about sexual health.72 The importance of language 
was also recognised as important in some studies.69
A not unexpected key theme in this review was privacy.7275 
Our findings complement a recent review calling for research 
that explores CYPs privacy and data security issues when using 
digital health technology to manage LTCs.76
Trust in the technology was another important factor to deter-
mine whether CYP would use a particular technology to manage 
a LTC. A recent review highlighted the importance of clinicians 
understanding CYPs needs in relation to their use of health 
technologies and also to help CYP identify appropriate tech-
nology.4 A study examining the concerns of CYP (without LTCs) 
also highlighted the concern, consistent across all age groups, of 
trust for health- related social media.77
Based on the concerns raised in the included studies within 
this review, we have developed a set of recommendations in 
conjunction with our CYP and parent stakeholders that we feel 
are important for future development and use of technology by 
CYP with LTCs (see box 1).
Strengths and limitations of the review
A strength of this review is its broad focus on technologies and 
LTCs in order to identify all information about CYPs concerns 
regarding use of technology to manage LTCs. We used recognised 
processes to ensure methodological rigour and consulted with 
CYP and parents. Due to the volume of records identified, we 
only reviewed full texts of articles that mentioned or alluded to 
concerns within the abstract. We did not include positive pref-
erences such as what CYP liked or preferred (eg, design features 
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Box 1 Recommendations
The following recommendations derive from our indings and are 
supported by the project stakeholders:
1. Ensure any technology for use by CYP is age and 
developmentally appropriate (in terms of language and style; 
if the technology is social media, then carefully consider the 
appropriate age range of participants).
2. CYP will want to use technology for different reasons 
and with different motivations (eg, some will want to use 
technology that connects them to others with the same 
condition for support, while others will not want to be 
segregated by their condition). Give CYP the option of how 
they use technology. Technology developers should involve 
CYP in the design and development of health technologies.
3. CYP may have concerns about using technology to manage 
an LTC, and these concerns should be considered alongside 
any potential beneits for CYP.
4. Trust will be an important factor for CYP using technology for 
their health; they will want to know how the technology has 
been developed, curated, tested and used previously in order 
to make an informed decision about whether they want to 
use it.
5. For technology involving images, recognise that CYP may not 
filter what they see and some may be surprised or concerned 
by distressing images (eg, on closed Facebook groups). A 
careful and sensitive approach should be taken to minimise 
CYP’s concerns.
6. Consider making the technology (eg, forums or text 
on websites) not overly negative, particularly consider 
moderation for peer communication, to avoid causing 
unnecessary anxiety for end users.
7. For any technology involving data, explain to CYP who will 
have access to their information, how their information will 
be stored and how CYP can change such access. Consider 
having a passcode or biometric protection for access 
to mobile apps, or where the operating system allows, 
prompting the use of these functions. Where messaging 
occurs, consider end- to- end encryption and self- destructing 
messages.
8. Recognise that CYP are taught digital safety in school, 
including caution around sharing their information, and may 
feel that doing so for the purposes of health technology 
contradicts this. They will want to know who will have access 
to their information and why.
In addition, stakeholders recommended the following:
9. Do not under- estimate CYP’s capabilities and the important 
input they can provide to technology development.
10. Consider gamification within technologies for younger CYP 
with LTCs.
11. When developing technology for use by CYP to manage 
LTCs, involve the appropriate group of CYP early in the 
process to ensure that the technology will be something 
they will want to use and will meet their needs. For example, 
if you plan to develop technology for CYP aged Y years with 
condition X, then work with CYP that are of this age with 
this condition.
12. Consider whether health inequalities may be created or 
exacerbated if the technology has a inancial cost associated 
with it.
13. Tell CYP what the actual impact of using the technology will 
be for them (eg, will it help them, are there any risks).
and interactivity elements). We note that many studies focus on 
positive preferences of CYP for technologies, and this may be an 
avenue for future research. Many of the included studies were 
conducted in high- income countries and findings may not gener-
alisable to CYP in low- income countries.
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